Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia.

Nature biomedical engineering - 1 Nov 2019

Hu C W, Qiu Y, Ligeralde A, Raybon A Y, Yoo S Y, Coombes K R, Qutub A A, Kornblau S M

Abstract excerpt

Acute myelogenous leukaemia (AML) is associated with risk factors that are largely unknown and with a heterogeneous response to treatment. Here, we provide a comprehensive quantitative understanding of AML proteomic heterogeneities and hallmarks by using the AML Proteome Atlas, a proteomics database that we have newly derived from MetaGalaxy analyses, for the proteomic profiling of 205 patients with AML and 111...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Factual
Share to Leukemia
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Proteins

Share to Proportional Hazards Models

Share to Proteome

Share to Proteomics

Share to Regression Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 30988472
DOI: 10.1038/s41551-019-0387-2
PMCID: PMC7051028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A quantitative analysis of heterogeneities and hallmarks in acute myelogenous leukaemia.PMID 30988472Read ↗

Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside agingSemantic proximity Read ↗

Proteomic Characterization of Acute Myeloid Leukemia for Precision MedicineSemantic proximity Read ↗

Molecular Characterization of the Highest Risk Adult Patients with Acute Myeloid Leukemia (AML) through Multi-omics ClusteringSemantic proximity Read ↗

Proteomic and phosphoproteomic landscapes of acute myeloid leukemia.Semantic proximity Read ↗

Functional proteomic profiling of AML predicts response and survivalSemantic proximity Read ↗

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.Semantic proximity Read ↗

Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia.Semantic proximity Read ↗

Molecular patterns identify distinct subclasses of myeloid neoplasia.Semantic proximity Read ↗

Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses.Semantic proximity Read ↗

Targeted therapy in acute myeloid leukemia: current status and new insights from a proteomic perspectiveSemantic proximity Read ↗

Mapping AML heterogeneity – multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responsesSemantic proximity Read ↗

Integrated OMICs unveil the bone-marrow microenvironment in human leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.